Ophthalmology·Danville, PA

Geisinger Health System

Signal lift13%72%+59 pp with a signal here
Allocate signal →Track an away here24-25 cycle · program-reported
Step 2 invited
p10 – p90
Interviewed
25
interviewed (latest year)
This cycle
no tracked aways yet
Match rate
8.0%
2 of 25 interviewed
01Cohort funnel24-25 cycle · program-reported
N = 25 interviewed
Interviewed
25
100.0%
Class size
2
8%
J-1 visa
Your fitGeisinger Health System Program

Create a free profile to see your personalized fit

Get started
Applicant profile2025 data

What successful applicants at this program look like.

See how competitive you are here

Compare your stats against applicants at Geisinger Health System Program

Create free account
Contact
BH
Program Director
Benjamin Patrick Hale, MD
Email director
MN
Program Coordinator
Michele A Noss
Email coordinator
Training sites3 hospitals · Danville
  • 1
    Geisinger Medical Center
    Danville, PA
    Primary
  • 2
    Geisinger Health System
    Danville, PA
    Sponsor
  • 3
    Wills Eye Hospital
    Philadelphia, PA
    Participant
Interview invites
Loading...
Rotator reports
No reports for this program yet
Rotated here? Be the first. 30 seconds, 3 taps, anonymous.
Score rangesinvited cohort

Step 2 CK data not available

Level 2 CE data not available

Interview rates
US MD
0%
US DO
0%
US IMG
0%
Non-US IMG
0%
Interview prepOphthalmology
personalTell me about yourself.★ common
specialtyWhy did you choose this specialty?★ common
programWhy are you interested in our program?★ common
behavioralWhat are your strengths and weaknesses?★ common
personalWhere do you see yourself in 5-10 years?★ common
Save this program

Add Geisinger Health System to your list

Build a personal match list. Compare programs side-by-side, see how your timing stacks against peers, and get notified when peers hear back.

Next

Calculate your match probability for Ophthalmology.

See how your profile compares across all programs.

Open calculator →

Data from NRMP 2025 Residency Explorer. Not medical advice. © 2026 Rezumab LLC.